Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||BHLH-PAS proteins in cancer|
|Citation:||Nature Reviews. Cancer, 2013; 13(12):827-841|
|Publisher:||Nature Publishing Group|
|David C. Bersten, Adrienne E. Sullivan, Daniel J. Peet & Murray L. Whitelaw|
|Abstract:||Mammalian basic HLH (helix–loop–helix)–PER–ARNT–SIM (bHLH–PAS) proteins are heterodimeric transcription factors that sense and respond to environmental signals (such as pollutants) or to physiological signals (for example, hypoxia and circadian rhythms) through their two PAS domains. PAS domains form a generic three-dimensional fold, which commonly contains an internal cavity capable of small-molecule binding and outer surfaces adept at protein–protein interactions. These proteins are important in several pro-tumour and antitumour pathways and their activities can be modulated by both natural metabolites and oncometabolites. Recently determined structures and successful small-moleculescreening programmes are now providing new opportunities to discover selective agonists and antagonists directed against this multitasking family of transcription factors.|
|Keywords:||Animals; Humans; Neoplasms; Cell Hypoxia; Gene Expression Regulation, Neoplastic; Circadian Rhythm; Basic Helix-Loop-Helix Transcription Factors; CLOCK Proteins; Circadian Clocks|
|Rights:||© 2013 Macmillan Publishers Limited. All rights reserved|
|Appears in Collections:||Molecular and Biomedical Science publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.